Inactive Instrument

Insiders Regen BioPharma, Inc. Other OTC

Equities

Regen BioPharma, Inc. Announces Board Appointments	07/22/07	CI
Regen Biopharma, Inc. Announces Board and Executive Changes	25/21/25	CI
Regen Biopharma, Inc. Announces Executive Changes	25/21/25	CI
Regen Biopharma, Inc. Announces Resignation of David Koos, as Chairman of the Board of Directors and as Chief Executive Officer	23/20/23	CI
Regen BioPharma, Inc. Appoints Todd S. Caven to Serve as A Member of the Board of Directors of the Company	19/19/19	CI
Regen BioPharma, Inc. Announces Executive Changes	26/19/26	CI
Regen BioPharma, Inc. Appoints Jean-Pierre million as Chairman of Newly Formed Business Advisory Board	30/17/30	CI
Regen BioPharma Inc. Announces Executive Changes	06/15/06	CI
Regen BioPharma Inc. Appoints Harry M. Lander as President	13/15/13	CI
Regen BioPharma Inc. Announces Executive Appointments	04/15/04	CI
Regen Biopharma, Inc. Appoints Todd S. Caven as Chief Financial Officer	13/15/13	CI
Regen Biopharma Inc. Appoints Amit Patel to its Scientific Advisory Board	15/14/15	CI
Regen BioPharma Inc. Announces Change of President	01/13/01	CI
Regen BioPharma Inc. Appoints Thomas E. Ichim as Chief Scientific Officer and Director of Research	26/12/26	CI
Regen BioPharma Inc. Appoints David White, Wei-Ping Min and Vlad Bogin to Scientific Advisory Board	06/12/06	CI
Regen BioPharma Inc. Appoints J. Christopher Mizer as President and Chief Operating Officer	08/12/08	CI

No results for this search